Commit To Buy Entrada Therapeutics At $12.50, Earn 55.6% Annualized Using Options
July 26, 2024 at 11:32 AM EDT
Investors eyeing a purchase of Entrada Therapeutics Inc (TRDA) stock, but tentative about paying the going market price of $17.13/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $12.50 strike, which has a bid at the time of this writing of $2.80..
